Back صناعات تيفا الصيدلانية Arabic صناعات تيفا الصيدلانيه ARZ Sicor Biotech BAT-SMG TEVA Bulgarian Teva Pharmaceutical Industries Ltd. Catalan Teva Pharmaceutical Industries Czech Teva German Teva Farmaciaj Industrioj Esperanto Teva Spanish صنایع دارویی تیوا Persian

Teva Pharmaceuticals

Teva Pharmaceutical Industries Ltd.
Company typePublic
IndustryPharmaceutical
Founded1901 (1901)
Founders
Headquarters
Tel Aviv
,
Israel[1]
Key people
RevenueIncrease US$15.8 billion (2023)[2]
Increase US$433 million (2023)[2]
Decrease US$−559 million (2023)[2]
Total assetsDecrease US$43.5 billion (2023)[2]
Total equityDecrease US$8.13 billion (2023)[2]
Number of employees
37,851 (2023)[2]
Websitetevapharm.com
teva.co.il
Günther Friedländer, founder of Teva Pharmaceutical Industries in Jerusalem

Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.[3]

Teva's primary branded products include Austedo (deutetrabenazine) which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy (fremanezumab), used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.

Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).[4][5]

Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 18th largest pharmaceutical company in the world.[6] Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.[7] In 2023, Teva paid the largest fine to date for a domestic antitrust cartel in relation to a criminal investigation by the US Department of Justice into the company's price-fixing.[8][9]

  1. ^ "TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Israel Company Reports – Search Israeli Companies". www.israelbizreg.com. Retrieved October 19, 2016.
  2. ^ a b c d e f "2023 Annual Report (Form 10-K)". US Securities and Exchange Commission. February 12, 2024.
  3. ^ Kiliç, Burcu (July 31, 2014). Boosting Pharmaceutical Innovation in the Post-TRIPS Era. Edward Elgar Publishing. ISBN 9781782544135. Retrieved May 23, 2017 – via Google Books.
  4. ^ "Teva wins controversial PhRMA bid despite protests from branded rivals – FiercePharma". www.fiercepharma.com. July 18, 2016. Retrieved May 23, 2017.
  5. ^ "Teva, one of the biggest generic makers, joins the brand-name club". STAT. July 18, 2016. Retrieved August 20, 2017.
  6. ^ "The top 20 pharma companies by 2020 revenue". FiercePharma. March 29, 2021. Retrieved June 15, 2021.
  7. ^ Cite error: The named reference :1 was invoked but never defined (see the help page).
  8. ^ Cite error: The named reference :2 was invoked but never defined (see the help page).
  9. ^ Cite error: The named reference reuters_2015_07_30 was invoked but never defined (see the help page).

Developed by StudentB